Free Trial Information
BioCentury | Dec 11, 2019
Financial News

Local demand high for Alphamab Oncology’s Hong Kong IPO

...IPO queue includes active applications from Akeso Inc., InnoCare Pharma Limited, Immunotech Biopharm Ltd. and Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Oct 28, 2019
Financial News

After Hong Kong IPO lull, local demand lifts Ascentage offering

...exchange’s biotech chapter: Immunotech Biopharm Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd.,Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Sep 18, 2019
Financial News

Hong Kong’s first IPO in months values Shanghai Henlius at $3.4B

...chapter including Immunotech Biopharm Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd., Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

Tasly Biopharma looks to list in Hong Kong Tasly Biopharmaceutical Co. Ltd. (Shanghai, China) proposed to list on the Hong Kong exchange. The company is a subsidiary of Tasly Pharmaceutical (Shanghai:600535), which holds 87.75% of...
Read More
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...latest example of a Chinese subsidiary looking to raise capital or restructure. In July, the Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...latest example of a Chinese subsidiary looking to raise capital or restructure. In July, the Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Aug 4, 2018
Finance

Hong Kong’s first wave

...to enter the queue in the mid-term include cancer play CStone Pharmaceuticals Co. Ltd. and Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Jul 11, 2018
Company News

Ally Bridge invests in Tasly Biopharmaceuticals

Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) said Wednesday it issued 75.7 million new shares, representing about 7% of the company, as it prepares for a possible IPO. The investors, which include Ally Bridge LB Healthcare...
Read More
BioCentury | Jul 10, 2018
Company News

Tasly Biopharmaceuticals gains control of JV ahead of possible IPO

Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) gained full control of its JV with Transgene S.A. (Euronext:TNG) and said it plans to list on the Hong Kong stock exchange. Tasly gained full rights in China, including...
Read More
Items per page:
1 - 9 of 9
BioCentury | Dec 11, 2019
Financial News

Local demand high for Alphamab Oncology’s Hong Kong IPO

...IPO queue includes active applications from Akeso Inc., InnoCare Pharma Limited, Immunotech Biopharm Ltd. and Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Oct 28, 2019
Financial News

After Hong Kong IPO lull, local demand lifts Ascentage offering

...exchange’s biotech chapter: Immunotech Biopharm Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd.,Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Sep 18, 2019
Financial News

Hong Kong’s first IPO in months values Shanghai Henlius at $3.4B

...chapter including Immunotech Biopharm Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd., Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

Tasly Biopharma looks to list in Hong Kong Tasly Biopharmaceutical Co. Ltd. (Shanghai, China) proposed to list on the Hong Kong exchange. The company is a subsidiary of Tasly Pharmaceutical (Shanghai:600535), which holds 87.75% of...
Read More
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...latest example of a Chinese subsidiary looking to raise capital or restructure. In July, the Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...latest example of a Chinese subsidiary looking to raise capital or restructure. In July, the Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Aug 4, 2018
Finance

Hong Kong’s first wave

...to enter the queue in the mid-term include cancer play CStone Pharmaceuticals Co. Ltd. and Tasly Biopharmaceuticals Co. Ltd....
Read More
BioCentury | Jul 11, 2018
Company News

Ally Bridge invests in Tasly Biopharmaceuticals

Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) said Wednesday it issued 75.7 million new shares, representing about 7% of the company, as it prepares for a possible IPO. The investors, which include Ally Bridge LB Healthcare...
Read More
BioCentury | Jul 10, 2018
Company News

Tasly Biopharmaceuticals gains control of JV ahead of possible IPO

Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) gained full control of its JV with Transgene S.A. (Euronext:TNG) and said it plans to list on the Hong Kong stock exchange. Tasly gained full rights in China, including...
Read More
Items per page:
1 - 9 of 9